Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.
Duo Oncology has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in February 2023.
Duo Oncology's investors include Ulu Ventures, BeiGene, Innovation Works, LifeX Labs, NuFund Venture Group.
Duo Oncology is headquartered in Pittsburgh, United States.
Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.
Duo Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Duo Oncology — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/duo-oncology. Accessed July 28, 2026.
VCBacked. (2023). Duo Oncology — Funding & Investors. Retrieved July 28, 2026, from https://www.vcbacked.co/company/duo-oncology
{{cite web |title=Duo Oncology — Funding & Investors |url=https://www.vcbacked.co/company/duo-oncology |website=VCBacked |access-date=July 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated